Amgen to reduce price of its cholesterol drug Repatha starting 2020 Medical Dialogues Bureau3 Nov 2019 9:15 AM ISTAmgen launched the lower-price option of Repatha last October, selling the drug to some patients under the list price of $5,850 per year because the...
Novartis, Gilead costly cancer therapies Yescarta, Kymriah losing patients to experimental treatments Medical Dialogues Bureau3 Aug 2019 9:15 AM ISTBoth Gilead's Yescarta and Novartis's Kymriah - which are part of a class of therapies known in the medical field as "CAR-T" - were approved in 2017....
Trump administration scraps key plan to reduce US drug prices Medical Dialogues Bureau12 July 2019 9:00 AM ISTThe decision represents a new setback to U.S. President Donald Trump's efforts to deliver on a pledge to lower drug prices for consumers before the...
Medicare hospital fund reserves likely to be exhausted in 2026: US report Medical Dialogues Bureau23 April 2019 9:00 AM ISTThe report from the board of trustees for Social Security and Medicare also projected that Social Security funds could be depleted by 2035, leading to...
Skeptical Democrats to quiz Trump health pick on drug prices Ruby Khatun Khatun1 Dec 2017 9:15 AM ISTWASHINGTON: Skeptical Democratic senators are getting a chance to question President Donald Trump's pick for health secretary about what he'll do...
